Sights set on ‘next-generation of medicines’

The new facility in Pfizer is designed to allow the Ringaskiddy site to manufacture tailored drugs that will work with your genetic code to beat illnesses.

The New Product Technology Laboratory (NPTL) is a move away from the huge bulk manufacturing of drugs in the thousands of kilos towards more potent, low-volume drugs.

Pfizer vice president Paul Duffy said some of these new drugs are produced commercially in tiny volumes compared to the blockbuster drugs of the 90s.